Fangfang Liu Selected Research

Lung Neoplasms (Lung Cancer)

4/2024	LncRNA MIR100HG affects the proliferation and metastasis of lung cancer cells through mediating the microRNA-5590-3p/DCBLD2 axis.
2/2024	Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5.
1/2022	CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer.
1/2022	NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.
10/2021	Lower lobe origin is related to unfavorable outcomes in patients with stage I-III lung cancer treated with radical chemoradiotherapy.
1/2021	Ceramide induces the apoptosis of non‑small cell lung cancer cells through the Txnip/Trx1 complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fangfang Liu Research Topics

Disease

73	Neoplasms (Cancer) 05/2024 - 01/2010
21	Breast Neoplasms (Breast Cancer) 12/2022 - 02/2010
17	Esophageal Squamous Cell Carcinoma 11/2023 - 06/2013
11	Neoplasm Metastasis (Metastasis) 04/2024 - 05/2009
10	Carcinoma (Carcinomatosis) 01/2023 - 01/2010
10	Inflammation (Inflammations) 12/2022 - 05/2015
8	Lymphatic Metastasis 09/2020 - 06/2010
6	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2021
6	Carcinogenesis 07/2023 - 01/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 01/2020
6	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 01/2010
5	Colonic Neoplasms (Colon Cancer) 09/2020 - 06/2014
5	Acute Lung Injury 01/2018 - 02/2013
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
4	Body Weight (Weight, Body) 03/2021 - 02/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 11/2015
4	Obesity 06/2019 - 01/2017
4	Adenocarcinoma 06/2018 - 01/2014
4	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 01/2014
3	Adenocarcinoma of Lung 02/2024 - 01/2021
3	Hypoxia (Hypoxemia) 01/2024 - 05/2014
3	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 12/2010
3	Hemorrhage 01/2022 - 05/2015
3	Triple Negative Breast Neoplasms 01/2021 - 01/2018
3	Disease Progression 05/2014 - 03/2010
2	Pain (Aches) 03/2024 - 10/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 12/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2021
2	Atherosclerosis 11/2022 - 05/2016
2	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 10/2019
2	Glioma (Gliomas) 01/2022 - 01/2022
2	Dyslipidemias (Dyslipidemia) 11/2021 - 06/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Acute Cholecystitis 01/2019 - 01/2019
2	Thrombosis (Thrombus) 01/2019 - 05/2015
2	Asthma (Bronchial Asthma) 01/2018 - 08/2013

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2013
14	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2013
7	MicroRNAs (MicroRNA)IBA 04/2024 - 06/2013
7	Messenger RNA (mRNA)IBA 12/2021 - 04/2013
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2016
5	Estrogen ReceptorsIBA 02/2018 - 01/2015
4	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2020
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2018
4	CytokinesIBA 12/2021 - 01/2015
4	LipopolysaccharidesIBA 10/2021 - 02/2013
4	LigandsIBA 10/2021 - 06/2010
4	Pyruvate KinaseIBA 05/2018 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2010
3	IntegrinsIBA 07/2023 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2015
3	Therapeutic UsesIBA 01/2023 - 07/2022
3	6-chloropenicillanic acid S-sulfoxideIBA 12/2021 - 03/2020
3	CholesterolIBA 11/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 04/2021 - 03/2010
3	ParaffinIBA 09/2020 - 01/2014
3	Coloring Agents (Dyes)IBA 01/2020 - 06/2016
3	CalciumIBA 11/2019 - 01/2018
3	Apolipoproteins E (ApoE)IBA 01/2019 - 05/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2015
3	taxaneIBA 01/2016 - 01/2015
3	AntigensIBA 11/2015 - 12/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 02/2013
2	B7-H1 AntigenIBA 04/2024 - 10/2019
2	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2019
2	MetalsIBA 02/2024 - 12/2019
2	Oxygen (Dioxygen)IBA 01/2024 - 05/2014
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 03/2021
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2022
2	GlycosidesIBA 01/2023 - 01/2022
2	LipidsIBA 01/2023 - 11/2022
2	CeramidesIBA 12/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 09/2019
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2018
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	bisphenol AIBA 01/2022 - 03/2021
2	3,3'-diindolylmethane (diindolylmethane)IBA 01/2022 - 01/2019
2	IodineIBA 01/2022 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 12/2021 - 11/2020
2	Butylated Hydroxyanisole (BHA)IBA 11/2021 - 06/2020
2	HDL CholesterolIBA 11/2021 - 06/2020
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 06/2020
2	LDL CholesterolIBA 11/2021 - 06/2020
2	oxidized low density lipoproteinIBA 11/2021 - 06/2020
2	Immunoglobulin E (IgE)IBA 10/2021 - 01/2018
2	Sialyl Lewis X AntigenIBA 04/2021 - 06/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 05/2016
2	ApolipoproteinsIBA 01/2019 - 05/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017

Therapy/Procedure

19	Therapeutics 04/2024 - 12/2010
9	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
8	Immunotherapy 05/2024 - 11/2011
5	Esophagectomy 11/2023 - 09/2022
4	Neoadjuvant Therapy 01/2021 - 09/2012
3	Radiotherapy 05/2021 - 01/2021
2	Photothermal Therapy 02/2024 - 01/2020
2	Precision Medicine 01/2022 - 01/2020
2	Gastrectomy 01/2020 - 06/2018
2	Cholecystostomy 01/2019 - 01/2019